Appointment booking for Dr. Daniel Carter, MD is currently not available.Dr. Daniel Carter, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Daniel Carter, MD (he/him) is a Pediatrician in Hoover, AL with over 15 years of experience. What is your opinion of Dr. Daniel Carter, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 15 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Daniel Carter, MD has received over $3,349 which includes payments from the following companies:
$909.86 from Shire North American Group Inc
$622.78 from Teva Pharmaceuticals USA, Inc.
$361.40 from Pfizer Inc.
$256.84 from Neos Therapeutics, LP
$134.43 from Tris Pharma Inc
$126.94 from Sanofi Pasteur Inc.
$126.88 from Meda Pharmaceuticals, Inc.
$95.66 from GlaxoSmithKline, LLC.
$82.06 from Arbor Pharmaceuticals, Inc.
$65.49 from AstraZeneca Pharmaceuticals LP
$64.50 from Mylan Specialty L.P.
$57.61 from Sobi, Inc
$56.77 from Merck Sharp & Dohme Corporation
$52.36 from Rhodes Pharmaceuticals L.P.
$49.97 from Takeda Pharmaceuticals U.S.A., Inc.
$45.24 from Genentech USA, Inc.
$38.52 from LILLY USA, LLC
$33.32 from Kaleo, Inc.
$29.92 from Mission Pharmacal Company
$27.94 from Adlon Therapeutics L.P.
Payments received by Dr. Daniel Carter, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!